Page:United States Statutes at Large Volume 114 Part 2.djvu/360

 114 STAT. 1242 PUBLIC LAW 106-310—OCT. 17, 2000 of this information targets the primary users of Ecstasy, who are most often college students, young professionals, and other young people from middle- to high-income families. (4) Greater emphasis needs to be placed on— (A) penalties associated with the manufacture, distribution, and use of Ecstasy; (B) the education of young people on the negative health effects of Ecstasy, since the reputation of Ecstasy as a "safe" drug is the most dangerous component of Ecstasy; (C) the education of State and local law enforcement agencies regarding the growing problem of Ecstasy traf- ficking across the United States; (D) reducing the number of deaths caused by Ecstasy use and the combined use of Ecstasy with other "club" drugs and alcohol; and (E) adequate funding for research by the National Institute on Drug Abuse to— (i) identify those most vulnerable to using Ecstasy and develop science-based prevention approaches tailored to the specific needs of individuals at high risk; (ii) understand how Ecstasy produces its toxic effects and how to reverse neurotoxic damage; (iii) develop treatments, including new medications and behavioral treatment approaches; (iv) better understand the effects that Ecstasy has on the developing children and adolescents; and (v) translate research findings into useful tools and ensure their effective dissemination. 28 USC 994 note. SEC. 3663. ENHANCED PUNISHMENT OF ECSTASY TRAFFICKERS. (a) AMENDMENT TO FEDERAL SENTENCING GUIDELINES.—Pursuant to its authority under section 994(p) of title 28, United States Code, the United States Sentencing Commission (referred to in this section as the "Commission") shall amend the Federal sentencing guidelines regarding any offense relating to the manufacture, importation, or exportation of, or trafficking in— (1) 3,4-methylenedioxy methamphetamine; (2) 3,4-methylenedioxy amphetamine; (3) 3,4-methylenedioxy-N-ethylamphetamine; (4) paramethoxymethamphetamine (PMA); or (5) any other controlled substance, as determined by the Commission in consultation with the Attorney General, that is marketed as Ecstasy and that has either a chemical structure substantially similar to that of 3,4-methylenedioxy methamphetamine or an effect on the central nervous system substantially similar to or greater than that of 3,4- methylenedioxy methamphetamine, including an attempt or conspiracy to commit an offense described in paragraph (1), (2), (3), (4), or (5) in violation of the Controlled Substances Act (21 U.S.C. 801 et seq.), the Controlled Substances Import and Export Act (21 U.S.C. 951 et seq.), or the Maritime Drug Law Enforcement Act (46 U.S.C. 1901 et seq.). (b) GENERAL REQUIREMENTS.— In carrying out this section, the Commission shall, with respect to each offense described in subsection (a)—

�